Cibinetide(Ara-290)For Bodybuilding CAS:1208243-50-8
Cibinetide (ARA-290), a synthetic peptide derived from erythropoietin (EPO), has garnered attention in niche bodybuilding circles for its potential to enhance recovery and mitigate inflammation. Unlike traditional EPO, it lacks erythropoietic effects, instead targeting tissue repair mechanisms. This guide explores its unique properties, applications, and controversies in bodybuilding, emphasizing evidence gaps and innovative usage strategies.
What is Cibinetide?
Origins & Structure:
Cibinetide is an 11-amino acid peptide, part of the EPO family, engineered to activate the Innate Repair Receptor (IRR) without stimulating red blood cell production. Developed for neuropathic pain and tissue injury, its mechanism diverges from conventional EPO by focusing on anti-inflammatory and cytoprotective pathways.
Key Distinctions from EPO:
●No hematocrit elevation, avoiding risks like thrombosis.
●Targets IRR complexes (EPOR/β-common receptor) to modulate immune responses and promote cellular repair.
Applications in Bodybuilding
A. Accelerated Muscle Recovery
●Mechanism: By downregulating NF-κB (a mediator of inflammation), Cibinetide reduces post-exercise muscle soreness and oxidative stress. Studies suggest it accelerates satellite cell activation, crucial for muscle repair.
●Practical Impact: Enables higher training frequency by shortening recovery windows.
B. Injury Mitigation
●Tendon/Ligament Health: IRR activation promotes collagen synthesis, beneficial for connective tissue resilience.
●Nerve Recovery: Addresses neuropathic pain from chronic heavy lifting, improving mobility.
C. Endurance Enhancement
●Indirectly supports endurance by reducing exercise-induced muscle damage, allowing sustained high-intensity efforts.
D. Synergy with Other Peptides
●Stacking Potential: Combines with BPC-157 (gut healing) or TB-500 (muscle repair) for holistic recovery.
Benefits for Bodybuilders
●Reduced DOMS (Delayed Onset Muscle Soreness): Faster return to training post-heavy sessions.
●Chronic Inflammation Management: Ideal for athletes with overuse injuries or autoimmune conditions.
●Non-Hormonal: Avoids androgenic side effects, making it suitable for natural competitors.
●Cognitive Benefits: Emerging data suggests neurogenesis effects, potentially improving focus during cuts.
Dosage Protocols
Research-Based Insights:
●Human Trials: Doses range from 1–4 mg/day for neuropathic pain. Bodybuilders often experiment with 2–6 mg/day, divided into 1–2 subcutaneous injections.
●Timing: Administered post-workout to capitalize on anti-inflammatory effects during the repair phase.
Factors Influencing Dosage:
●Body Weight: 0.03–0.05 mg/kg.
●Cycle Goals: Bulking phases may require higher doses due to increased tissue stress.
Cycling Strategies
Typical Cycles:
●Beginner: 4–6 weeks at 2 mg/day, followed by a 4-week washout to prevent receptor desensitization.
●Advanced: 8 weeks at 4 mg/day, paired with collagen supplements for tendon support.
Pulse Dosing:
Some users adopt 5-days-on/2-days-off schedules to maintain IRR sensitivity.
Half-Life & Administration
●Half-Life: ~2–4 hours, necessitating twice-daily dosing for sustained effects.
●Optimal Timing: Morning and post-training injections to align with cortisol rhythms and muscle repair windows.
PTC (Post-Treatment Considerations)
Note: PTC is not a standard term in this context. Assuming it refers to post-cycle therapy:
●Relevance: Unlike anabolic steroids, Cibinetide doesn't suppress HPA axis function, eliminating the need for traditional PCT.
●Recommendations: A 4-week break between cycles to reset IRR responsiveness. Monitor inflammatory markers via blood tests.
Safety & Side Effects
●Reported Issues: Mild injection-site reactions; no significant toxicity in trials.
●Theoretical Risks: Prolonged immune modulation could increase infection susceptibility.
●Contraindications: Avoid with immunosuppressive therapies or active infections.
Legal & Ethical Status
●WADA Compliance: Not explicitly banned, but its EPO-derived structure may raise anti-doping flags.
●Research Chemical Status: Sold for "lab use only," posing legal ambiguities for personal use.
Future Directions & Research Gaps
●Human Trials Needed: Current data focuses on neuropathy; muscle-specific studies are lacking.
●Long-Term Efficacy: Unknown if benefits plateau with prolonged use.
●Combination Therapies: Exploration with myostatin inhibitors or SARMs for synergistic hypertrophy effects.
Clinical Data
|
Trade names |
Cibinetide,ARA-290; ARA290; PHBSP,pHBSP peptide; pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser;Pyroglutamate helix B surface peptide; UEQLERALNSS |
|
CAS |
1208243-50-8 |
|
Molar mass |
1257.324 |
|
Formula |
C51H84N16O21 |
|
Purity |
Above 98% |
|
Apprarance |
10mg/vial, 10vials/box |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-19128233885
Conclusion
Cibinetide offers a novel, non-hormonal avenue for bodybuilders prioritizing recovery and inflammation control. While preclinical data is promising, empirical evidence in athletic populations remains sparse. Users should approach with caution, prioritize third-party testing for purity, and consult healthcare professionals. As research evolves, Cibinetide may redefine peptide protocols in sports science.
Hot Tags: cibinetide(ara-290)for bodybuilding cas:1208243-50-8, China cibinetide(ara-290)for bodybuilding cas:1208243-50-8 manufacturers, suppliers, factory, Boldenone Undecylenate, Fluoxymethelone, Nolvadex to treat or prevent breast cancer, Steroid Raw Powders Injectables, Testosterone Phenylpropionate, Toremifene Citrate
